In the published article, there was an error Figure 3A and its legend as published. The TF was inadvertently misused during the final assembly of Figure 3A. The corrected Figure 3 its caption appears below.
FIGURE 3
In the published article, there was an error Figure 7A and its legend as published. The TF was inadvertently misused during the final assembly of Figure 7A. The corrected Figure 7 its caption appears below.
FIGURE 7
In the published article, there was an error. The anti-TF antibody’s manufacturer and batch number are incorrect.
A correction has been made to 2. Materials and methods, 2.1 Animal experiments, Paragraph Number 1. This sentence previously stated:
“In the experimental groups, mice were immediately injected with recombinant Chi3l1 (500 ng, Sino Biological, 50929-M08H), anti-Chi3l1 antibody (500 ng, Sino Biological, 50929-RP01), or anti-TF antibody (1/1,000, 500 μg, ProteinTech, 17435-1-AP) after receiving ConA (Shan et al., 2018).”
The corrected sentence appears below:
“In the experimental groups, mice were immediately injected with recombinant Chi3l1 (500 ng, Sino Biological, 50929-M08H), anti-Chi3l1 antibody (500 ng, Sino Biological, 50929-RP01), or anti-TF antibody (1/1,000, 500 μg, Bioss, bs-4690R) after receiving ConA (Shan et al., 2018).”
In the published article, there was an error. The anti-TF antibody’s manufacturer and batch number are incorrect.
A correction has been made to 2. Materials and methods, 2.4 Western blot analysis, Paragraph Number 1. This sentence previously stated:
“The membrane was then blocked with a rapid blocking solution and incubated with the specific primary antibodies against TF (ProteinTech, 17435-1-AP, 1/3,000), PAR1 (Solarbio, K009690P, 1/1,500), CCL2/MCP-1 (ProteinTech, 25542-1-AP, 1/2,000), and CXCL10/IP-10 (ProteinTech, 10937-1-AP, 1/500).”
The corrected sentence appears below:
“The membrane was then blocked with a rapid blocking solution and incubated with the specific primary antibodies against TF (Bioss, bs-4690R, 1/1,000), PAR1 (Solarbio, K009690P, 1/1,500), CCL2/MCP-1 (ProteinTech, 25542-1-AP, 1/2,000), and CXCL10/IP-10 (ProteinTech, 10937-1-AP, 1/500).”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
YKL-40, TF-PAR1 pathway, inflammation, liver injury, CCL2, IP-10
Citation
Jing-Lun Z, Shuang C, Li-Mei Z and Xiao-Dong L (2024) Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice. Front. Pharmacol. 15:1395496. doi: 10.3389/fphar.2024.1395496
Received
04 March 2024
Accepted
05 August 2024
Published
15 August 2024
Volume
15 - 2024
Edited by
Patricia Moriel, State University of Campinas, Brazil
Reviewed by
Ning Zhang, Fudan University, China
Updates
Copyright
© 2024 Jing-Lun, Shuang, Li-Mei and Xiao-Dong.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Liu Xiao-Dong, liuxd@sj-hospital.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.